Image-guided interventional surgery firm Stereotaxis of St. Louis posted continued record revenue for its third quarter.
For the period (end-September 30), revenue increased 58% to $12 million, compared to $7.6 million for the same period in 2006. Revenue from Niobe system sales grew 49% to $9.5 million, compared with $6.4 million in 2006 due to an increase in both the number of systems sold and the average selling price. The company's net loss for the quarter totaled $10.4 million, compared to $11.4 million in 2006.
For the first nine months of 2007, revenue totaled $29 million, compared to $13.2 million for the same period in 2006. Net loss for the first six months of the year was $35.9 million versus $39.6 million in 2006.
By AuntMinnie.com staff writers
November 8, 2007
Related Reading
Stereotaxis growth in Q2 sales, net loss, August 10, 2007
Stereotaxis gets FDA OK for ablation catheter, April 3, 2007
Stereotaxis hits procedure milestone, January 25, 2007
Stereotaxis shows Q3 revenue gain, November 10, 2006
Stereotaxis, Medtronic partner for clinical study, May 18, 2006
Copyright © 2007 AuntMinnie.com